Loading...
Loading...
shares rose 36.55 percent to $0.526 in pre-market trading. On Tuesday, Maxim Group initiated coverage on Opexa Therapeutics with a Buy rating and a $5.00 price target.
Five Prime Therapeutics IncFPRX shares surged 18.45 percent to $23.30 in pre-market trading on news that it has licensed certain antibodies to
Bluebird Bio Inc. BLUE.
Tiffany & Co.TIF gained 7.92 percent to $92.30 in pre-market trading after the company reported stronger-than-expected results for the first quarter on Wednesday.
Cellectis SA (ADR) CLLS shares climbed 7.71 percent to $39.26 in pre-market trading after rising 7.21 percent on Tuesday.
TiVo Inc. TIVO shares gained 4.73 percent to $10.85 in the pre-market trading session after the company reported upbeat results for the first quarter.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in